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Summary 
Proteinase inhibitors were isolated from aqueous and 
acidic extracts of dog submandibular glands employing 
gradient elution and equilibrium chromatography on 
CM-cellulose. Mainly four inhibitors were obtained 
which differ only slightly in amino acid composition 
(cf. Table 2 and 3). Molecular weights of 12750 up to 
12878 were calculated for the different components. 
The following enzymes are strongly inhibited: bovine 
trypsin and cx-chymotrypsin, subtilisin Novo, porcine 
pancreatic elastase, Aspergillus Oryzae protease, plasmin 
(pig), and part of the proteolytic activity of pronase. No 
inhibition of collagenase was found. The dog submandi-
bular inhibitor (DSI) is double-headed; the two different 
reactive sites do not overlap : The DSI-chymotrypsin and 
the DSI-subtilisin complex — both complexes contain 
equimolar amounts of enzyme and inhibitor — are able 
to bind an additional trypsin molecule so that ternary 
complexes are formed. 
The potential physiological function as well as the signi-
ficance of DSI for medical problems are discussed. 
Introduction 
The physiological role o£ pancreatic trypsin in-
hibitors, described in some foregoing papers 
[1—4], seems to be obvious: Inhibition of 
premature activation of trypsinogen with all its 
severe consequences in the gland. The high 
concentrations of proteinase inhibitors found in 
other organs of various animals [5] may protect 
them against the action of trypsin-like and 
chymotrypsin-like proteinases. 
The highest concentration of a proteinase in-
hibitor found until now in animal tissues exists 
in submandibular glands of dogs [5]. Depending 
on the state of the gland l g of fresh tissue 
contains maximal 5 mg inhibitor. This inhibitor 
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was discovered by T R A U T S C H O L D , W E R L E , 
H A E N D L E and S E B E N I N G [6] and described in 
more detail by T R A U T S C H O L D [7] and H A E N D L E 
[8]. Some of the results were presented in earlier 
lectures given by T R A U T S C H O L D [9, 10]. Similar 
to the pancreatic trypsin inhibitors [1—4] the 
dog submandibular proteinase inhibitor is also 
a secretory protein [8]. 
Abbreviations: B A P N A , Na-benzoyl-DL-arginine 
p-nitroanilide; BPTI, basic pancreatic trypsin inhibitor 
(Kunitz-type) = trypsin-kallikrein inhibitor from bovine 
organs; C M , carboxymethyl; CPPN, N-3-(carboxypro-
pionyl)-L-phenylalanine p-nitroanilide; M . W., molecular 
weight; T R A , triethanolamine; TRIS, trishydroxy-
methyl aminomethane. 
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Methods 
I s o l a t i o n P rocedure 
Extraction and Purification Steps: Dog submandi-
bular glands from Peele Freeze, Biologicals 
(USA), containing 10—14 I U (trypsin in-
hibition) per g tissue, were thawed and homo-
genized in deionized ice water (2 / for 100 g 
glands). After centrifugation the supernatant 
was adjusted to p H 6.0—6.5 and stirred with 
100 g CM-cellulose (H +-form) for two hours in 
an ice bath. The CM-cellulose adsorbate was 
washed 3 times with 500 m/ 0.01M sodium 
acetate, p H 5.0. In order to elute the inhibitor 
the adsorbate was suspended in 5% (w/w) NaCl , 
0.01M TRA-HC1 , p H 8.0, for 10 minutes. By 
repeated elution 90—95% of the inhibitory 
activity found in the homogenate was recovered 
in the supernatant eluates of the cellulose. 
The main salt portions were separated by 
dialysation: 4 hours, deionized water, 0—4°C. 
Concentration (evaporation in vacuo) was 
followed by fractionation on Sephadex G-50 
columns equilibrated and developed with 
aqueous (5%, V/V) acetic acid. Lyophilisation of 
the inhibitor containing eluates yielded a white 
powder with a specific activity of 1.4 up to 
1.8 I U (trypsin inhibition) per mg. Loss of about 
18% of the inhibitor was observed during these 
steps. 
Another part of the inhibitor material was 
isolated from acidified extracts (perchloric acid, 
3%, w/w) of the homogenates [6, 7, 8]. In this 
case the supernatant of the precipitated proteins 
was neutralized with 5M K 2 C 0 3 solution. 
Precipitated K C 1 0 4 was separated by filtration, 
and the inhibitor solution was diluted with 
water 1:5 before adding CM-cellulose. 
Chromatographic Separations: Depending on the 
foregoing isolation procedure somewhat dif-
ferent methods were employed. 
1) The following chromatographic systems were 
used for further purification of the inhibitor 
material isolated from perchloric acid extracts of the 
homogenates : 
/—1) Gradient elution chromatography on C M -
cellulose (Fig. 1); 
1—2) Gel filtration on Biogel P-2 (5.0 x 30 cm), 
equilibrated and developed with 0.01M acetic 
acid (followed by lyophilisation of the inhibitor-
containing eluate) ; 
7—3) Rechromatography on CM-cellulose of 
each of the two fractions I * and I I* shown in 
Figure 1 under the same conditions as given in 
the legend of Figure 1, except that the slope 
of the NaCl-gradient was only 2/3 of the one 
described; 
/—4) Ge l Filtration on Biogel P-2 (for condi-
tions see step 1—2) followed by lyophili-
sation of the eluted inhibitor containing 
fractions. 
The amino acid composition of the two in-
hibitor fractions I * and II* thus obtained is 
given in Table 2. 
2) For further purification of the inhibitor 
material isolated from aqueous extracts the follow-
ing systems were employed: 
2— 1) Gradient elution chromatography on 
CM-cellulose as shown in Figure 1 yielding 
fractions 2-1 and 2-II (a somewhat modified 
gradient was used: 0,5M NaCl to 0.05M NaCl , 
each in the elution buffer.); 
2—2) Ultrafiltration of the inhibitor fractions in 
Amicon cells (membrane: UM-2) by repeated 
dilution with deionized water; 
2—3) Equilibrium chromatography on C M -
cellulose of fraction 2-1 (Fig. 2) and fraction 2-II 
(Fig. 3) in separate runs ; 
2—4) Ultrafiltration of the inhibitor fraction A 2 
shown in Figure 2 followed by rechromato-
graphy under identical conditions as given in 
Figure 2, except the length of the column used 
(twice as high, complete separation of fractions 
A1 and A 2 , cf. legend of Fig. 2, section 
2-2). 
2—5) Ge l filtration of the rechromatographed 
inhibitor fraction A 2 and of the inhibitor 
fraction C (shown in Fig . 3) on Sephadex G-50 
equilibrated and developed with aqueous acetic 
acid (5%, V/V) followed by lyophilisation of the 
inhibitor-containing fractions. 
The amino acid composition of the two inhi-
bitor fractions A 2 and C thus obtained is given 
in Table 3. 
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D e t e r m i n a t i o n of E n z y m e A c t i v i t y and 
E n z y m e I n h i b i t i o n 
Trypsin: The activity of trypsin and trypsin 
inhibition was measured with N a -benzoyl-DL-
arginine p-nitroanilide (BAPNA) as substrate. 
Details are given in ref. [11, 12] . One mU 
corresponds to about 1 fig trypsin; bovine 
trypsin (Novo Industri A/S) was used through-
out. One unit of inhibition activity (IU) causes 
the reduction of B A P N A hydrolysis by 1 //mole 
per minute, one m l U the 1 0 - 3 fold amount. 
The molarity of the trypsin solutions used in the 
titration experiments (Fig. 5) was determined 
according to C H A S E and S H A W [13] and by in-
hibition tests with an inhibitor (BPTI) solution 
of known molarity [14]. 
Chymotrypsin: N - 3 - (carboxypropionyl)-L-phenyl-
alanine p-nitroanilide (CPPN) was applied as 
substrate. Details are given in ref. [12, 15]. 
Definitions correspond to the ones mentioned 
above. Bovine cc-chy mo trypsin (Novo Industri 
A/S, 1100 N F per mg) was used throughout. 
One m U corresponds to about 2 0 fig #-chymo-
trypsin. 
The molarity of the chymotrypsin solutions 
used in the titration experiments (Fig. 7) was 
determined by inhibition tests with an inhibitor 
(BPTI) solution of known molarity [14]. 
Plasmin: Plasmin activity and plasmin inhibition 
was measured with B A P N A as substrate. Assay 
conditions were the same as for trypsin [11, 12] 
except for the presence of 0 . 05M L-lysine in the 
buffer solution. Increase in extinction was 
observed for 10 minutes [12]. Plasmin from 
pig (batch 25-S-68 , 2 .68 Novo units per mg) 
was a gift from Novo Industri A/S. For the 
stock solution 10 mg plasmin were solved in 
4.0 m/ 0.0025N H C l . The molarity of the 
plasmin solution used in the titration experi-
ments (Fig. 6) was determined by inhibition tests 
with an inhibitor (BPTI) solution of known 
molarity [14]. 
Subtilisin, Aspergillus Ory^ae Protease, Pronase: 
Proteinase activity and enzyme inhibition was 
measured with azo-casein (Pentex-PP 6262, 
Fluka A G ) as substrate. Constant amounts of 
17* 
the enzymes were incubated with increasing 
amounts of inhibitor in 1.0 ml 0.1M sodium 
potassium phosphate buffer, p H 7.6, for 5 mi-
nutes at 30° C. Afterwards 2.0 m/ azo-casein 
solution (2%, w/w) in the same buffer was added 
and the mixture incubated for 10 minutes at 
30° C. The enzymatic reaction was stopped by 
addition of 3.0 ml aqueous trichloracetic acid 
(5%, w/w). After 30 minutes at room tempera-
ture the extinction of the supernatant was read 
against a blank at 366 nm. The assay procedure 
is described in more detail in ref. [12], p. 1029. 
Subtilisin (Crystalline Bacterial Proteinase, 22.0 
Anson trypsin units per g, Batch 50-2) was 
a gift from Novo Industri A/S. Pronase E 
(lyophil, 70000 PUK/g from Streptomyces 
griseus) was purchased from Merck A G and 
alkaline Aspergillus Oryzae Protease (highly 
purified, 3500 P U (pH 8)/mg protein) from 
Röhm & Haas G m b H , Darmstadt. 
Elastase: The activity of elastase from pig 
pancreas (cryst., suspension, 15 E/mg, from 
Merck A G ) was measured according to the 
method published by S A C H A R et al. [16] with 
elastin-orcein (Merck A G ) as substrate. Elastase 
inhibition was determined in the following 
manner: A mixture of 0.15 ml of the elastase 
suspension (containing about 0.75 mg elastase 
in 0.2M TRIS-HC1, p H 8.8) and the inhibitor 
solution was filled up to 1.50 ml with 0.2M 
TRIS-HC1, p H 8.8. This incubation mixture was 
briefly (5 minutes) shaken and admixed with 
20 mg elastin-orcein. The test sample was 
vigorously shaken for 30 minutes at room 
temperature. The enzymatic reaction was stopped 
by addition of 2.0 ml 0.5M phosphate buffer, 
p H 6.0. After centrifugation the extinction of the 
supernatant was read against a blank at 578 nm. 
Results and Discussion 
I s o l a t i o n of Inh ib i t o r s 
The developement of simpler isolation methods 
as described for dog submandibular inhibitor 
[6—10] was necessary in order to obtain enough 
material for sequential studies [18]. The method 
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presented includes only a few steps, repeated 
chromatography on CM-cellulose and gel filtra-
tion or ultrafiltration, each with high yield in 
inhibitory activity. 
From perchloric acid extracts of the glands — in 
which all proteases are inactivated — two in-
hibitor fractions were obtained by gradient 
elution chromatography (Fig. 1) in about equal 
amounts (Tab. 1, I e). Both fractions differ only 
slightly in amino acid composition: Fraction I * 
contains 1 more glutamic acid residue and 1 
lysine residue less than fraction I I* (Tab. 2). 
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Fig. 1. Gradient Elution Chromatography on C M -
Cellulose. Inhibitor material isolated from perchloric 
acid extracts (see Methods) was employed. 100—140 mg, 
dissolved in 1.0 ml of the starting buffer, were applied 
to the column (1. 6 X 30 cm) which was equilibrated 
and developed with 0.01M TRA-HC1, p H 8.0, at 10.5 ml 
per hour. As soon as the protein content and the inhibi-
tory activity in the eluate decreased, a linear gradient 
formed from 0.5 liters each of starting buffer and 0.01M 
TRA-HC1, 0.3M NaCl, pH 8.0, was used for elution. 
Inhibitor fraction I* appeared in the eluate at a NaCl 
concentration of about 0.04M, inhibitor fraction II* 
at 0.08M. Yields are given in Table 1. 
Using the same chromatographic procedure 
from aqueous extracts of the glands an inhibitor 
fraction I (termed "2-1") was obtained in an 
amount that was about twice as high as that of 
fraction II (termed "2-11", cf. Tab. 1, l d ) , how-
ever, both fractions were not homogeneous. 
Further purification by equilibrium chromato-
graphy was necessary (Fig. 2 and 3): 
O 4 * 
T U B E N O , 5 m l / T U B E 
F R A C T I O N l A , ! A 2 I 
Fig. 2. Equilibrium Chromatography of Fraction 2-1, 
obtained by Gradient Elution Chromatography. Condi-
tions were the same as given in Fig. 4 ; however columns 
with deviating dimensions were employed. 
2-1) 228 IU (trypsin inhibition) were applied to the 
column (2.0 x 30 cm). The elution curve is shown in 
the Figure. Elution rate: 12 ml per hour. 
2-2) Complete separation of fractions A1 and A2 is 
achieved by using a longer column (2.0 x 65 cm) and 
a smaller elution rate (6 ml per hour, cf. Table 1). 
For distribution of inhibitory activity in the eluted frac-
tions and yields see Table 1. 
TUBE NO 4 .0ml /TUBE — 
m I "I 
Fig. 3. Equilibrium Chromatography of Fraction 2-II, 
obtained by Gradient Elution Chromatography. The 
column and the conditions described in Fig. 4 were used. 
255 IU (trypsin inhibition) were applied. For distribution 
of inhibitory activity in the eluted fractions see Table 1. 
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Table 1. Distribution of Inhibitory Activity among the Fractions obtained by Gradient Elution and Equilibrium 
Chromatography 
Important intermediate fractions are put in parenthesis 
Fractions Number Percent* of inhibitory activity (trypsin inhibition) found in the given Total yield 0 
from Fig. of runs fractions [%]a 
Gradient elution chromatography 
I II 
3 32—38* (10—12) 26—28* (12-15) 97—100 
Id 3 45—51 (9-25) 22—29 (4-8) 94—100 
E q u i l i b r i u n i chromatography 
A x A 2 B C 
4 1 14 50 7 28 99 
2* 3 17—27 53—71 87—97 
2' 3 1—2 87—99* 95—100 
3S 1 8 27 54* 95 
a Related to the inhibitory activity applied to the column. 
b Including all fractions containing inhibitory activity. 
c Inhibitors isolated from perchloric acid extracts of the glands (see Methods). 
d Inhibitors isolated from aqueous extracts of the glands (see Methods). 
e Fraction I (from l d ) served as starting material; the short column described in Figure 2 was used. 
f Fraction I (from l d ) and fraction A 2 (from 2 e ; rechromatography 1) served as starting material; the long column 
described in Figure 2 was used. 
8 Fraction II (from l d ) served as starting material. 
* These inhibitor fractions were used, after gel filtration (Sephadex G-50, 5% (w/w) acetic acid) and lyophilisation, 
for further investigations. 
1) After complete separation of an inactive con-
tamination A j from] fraction I (see legend of 
Fig . 2 and Tab. 1, 2 e and 2*) an inhibitor A 2 
was obtained which has the same amino acid 
composition (Tab. 3) as inhibitor fraction I * 
which was isolated from acidic extracts. 
2) Inhibitor C, obtained from fraction II (cf. 
Fig. 3 and Tab. 1, 3«) was found to lack a single 
residue each of glycine and proline, when 
compared to inhibitor fraction II 1 . Probably 
glycine and proline are split off by exo-
peptidases* in the aqueous extracts of the glands, 
whereas the glutamic acid residues is also absent 
in inhibitor fraction I I* isolated from acidic 
extracts. 
1 Glycine was determined as the only N-terminal re-
sidue by H . TSCHESCHE and E . FINK. 
Therefore the assumption is logical that sub-
mandibular glands of dogs contain two very 
similar inhibitors, one of them synthesized by 
a mutated gene, which differ only in one G l u 
and one Lys residue. This is astonishing in so 
far as the glands were collected from different 
breeds. The occurrence of isoinhibitors is also 
described by other authors [19—24]. 
In order to find out the proportions of the in-
hibitor fractions in the material obtained from 
aqueous extracts a sample was subjected directly 
to equilibrium chromatography (Fig. 4). The 
portion of the main fractions A 2 and C, which 
are identical with the corresponding inhibitor 
fractions shown in Figures 2 and 3, amounts 
to 92% of the total inhibitory activity found in 
this sample (cf. Tab. 1 ; the inhibitory activity in 
fraction Ax belongs to A 2 , see 2 e and 2* in Tab. 1 
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Table 2. Amino Acid Composition (Residues per Molecule) of DSI-Fractions Isolated from Acidic Extracts Using 
Gradient Elution Chromatography 
Fraction I* (Fig. 1, Table 1) II* (Fig. 1, Table 1) 
20 hrs 70 hrs Integer 20 hrs 70 hrs Integer 
Cysteic acid 12.06a (12) 12.19* (12) 
Methionine sulfone 3.16a (3) 2.84a (3) 
Aspartic acid 13.33 13.18 13 13.17 13.09 13 
Threonine 6.71 6.59 7 6.70 6.45 7 
Serine 7.81 6.99 8 7.64 6.79 8 
Glutamic acid 8.88 9.33 9 8.02 8.16 8 
Proline 5.87 6.03 6 5.84 6.27 6 
Glycine 8.91 9.24 9 8.79 9.09 9 
Alanine 6.07 6.19 6 5.86 6.14 6 
Half-cystine 10.56 10.10 12* 11.60 9.87 12* 
Valine 2.66 4.00 4 2.74 3.74c 4 
Methionine 2.28 2.90 3* 2.22 2.47 3* 
Isoleucine 4.33 5.27 5 4.45 5.24d 5 
Leucine 5.96 6.23 6 5.82 6.18 6 
Tyrosine 4.95 4.54 5 4.93 4.25 5 
Phenylalanine 3.96 4.09 4 3.86 4.00 4 
Lysine 9.90 9.87 10 10.91 10.89 11 
Histidine 3.08 3.08 3 2.80 3.04 3 
Arginine 4.84 5.17 5 4.69 4.84 5 
Tryptophan0 0.3 0 0.4 0 
Total 
Mol. weight' 
115 
12750 
115 
12750 
a After performic acid oxidation. 
b Calculated from the values of the oxidized inhibitor (cf. a). 
c 120hrs: 3.89 residues. 
d 120hrs: 5.06 residues. 
e Spectrophotometric determination [17]. 
f Degree of amidination is not considered. 
and Fig . 2). Fraction B is not yet further in-
vestigated. These results show that enzymatic 
degradation in the aqueous extracts of the glands 
is limited and causes no serious disadvantages. 
On the other hand some of the inhibitor is 
adsorbed by the precipitated protein and must be 
eluted by repeated extractions if the extracts are 
acidified with perchloric acid. 
A m i n o A c i d C o m p o s i t i o n 
The amino acid compositions of the isolated 
inhibitor fractions are shown in Tables 2 and 3. 
The small differences in the content of glutamic 
acid, lysine, glycine and proline are already 
discussed in the preceding paragraph. Further-
more, the following should be mentioned : When 
based on the molecular weight the number of 
disulfide bridges corresponds to that of many 
other inhibitors obtained from animal organs 
(e. g. pancreas glands, bovine organs, seminal 
vesicles, etc.). Values obtained by the one-
column method were used to coordinate the 
numbers of basic and neutral or acidic amino 
acid residues. Release of arginine and isoleucine 
is finished only after a hydrolysis time of 70 
Proteinase Inhibitors from Dog Submandibular Glands 
Table 3. Amino Acid Composition (Residues per Molecule) of DSI-Fractions Isolated from Aqueous Extracts Using 
Gradient Elution and Equilibrium Chromatography 
A 2 (Fig. 2, Table 1) C (Fig. 3, Table 1) 
Fraction 20 hrs 70 hrs Integer 20 hrs 70 hrs Integer 
Cysteic acid 11.68a (12) 11.75* (12) 
Methionine sulfone 2.90a (3) 2.98* (3) 
Aspartic acid 13.13 13.17 13 13.22 13.18 13 
Threonine 6.95 6.74 7 6.96 6.80 7 
Serine 7.90 7.06 8 7.78 7.53 8 
Glutamic acid 9.05 8.92 9 8.12 8.34 8 
Proline 6.19 5.92 6 4.86 5.05 5 
Glycine 8.99 8.97 9 8.25 8.43 8 
Alanine 5.99 5.97 6 5.98 6.15 6 
Half-cystine 11.41 9.89 12* 10.59 10.99 12* 
Valine 2.75 3.82 4 2.90 3.84 4 
Methionine 3* 3* 
Isoleucine 4.64 5.12 5 4.90 5.08 5 
Leucine 6.15 6.17 6 6.03 6.15 6 
Tyrosine 4.82 4.46 5 4.68 4.53 5 
Phenylalanine 3.85 3.93 4 3.75 4.02 4 
Lysine 9.97 10.08 10 11.10 11.30 11 
Histidine 3.06 3.09 3 2.98 3.09 3 
Arginine 4.88 4.98 5 4.57 5.02 5 
Tryptophan0 0.35 0 
Total 
Mol. weightd 
115 
12750 
113 
12595 
a After performic acid oxidation. c Spectrophotometric determination [17]. 
* Calculated from the values of the oxidized inhibitor. d Degree of amidination is not considered. 
Fig. 4. Equilibrium Chromatography 
on CM-Cellulose. Inhibitor material 
isolated from aqueous extracts was 
employed. 100—150 mg (dissolved 
in 5.0 ml of the elution buffer) were 
applied to the column (2.0 X 30 cm), 
which was equilibrated and develo-
ped with 0.05M NaCl, 0.01M T R A -
HC1, p H 8.5, at 12 ml per hour. D i -
stribution of inhibitory activity in 
the eluted fractions and yields are 
presented in Table 1. 
1 
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hours. Due to methodical difficulties the values 
of tryptophan and proline must be verified 
in the course of sequential studies. The presence 
of carbohydrate residues in the DSI-molecules 
was not observed. 
M o l e c u l a r W e i g h t 
For the molecular weight of DSI-fraction A 2 the 
following values were obtained by different 
methods : 
1) Calculated from amino acid compo-
sition (Tab. 3) 12750 
2) From gel filtration experiments (Tab. 4) 12000 
3) From ultracentrifuge studies [25] 11900 
4) Calculated from the specific activity 
(2.5 I U per mg, trypsin inhibition) 13200 
The values are in good agreement with each 
other and with those reported in the litera-
ture [9, 10, 26, 27]. DSI forms a ternary 
complex with trypsin and chymotrypsin (Tab. 4). 
Dissociation of DSI into subunits during com-
plex formation may therefore be excluded; it is 
also improbable regarding the amino acid com-
position. 
Some observations indicate that less pure pre-
parations of DSI may bind two trypsin molecules 
per molecule inhibitor. Perhaps in this state the 
reactive site for chymotrypsin can bind a trypsin 
molecule, too. But we have no evidence that the 
pure DSI-molecule binds two trypsin molecules 
as might be deduced from the specific activity of 
earlier obtained preparations [7—10]. 
I n h i b i t i o n Spec t rum 
DSI inhibits strongly the following proteinases : 
Bovine trypsin (Fig. 5) and oc-chy mo trypsin (Fig. 7), 
subtilisin Novo (Fig. 8), porcine pancreatic 
elastase (Fig. 9) and alkaline A. ory^ae protease 
(Fig. 10). In these cases one enzyme molecule 
reacts with one inhibitor molecule to form the 
complex under the conditions employed. This 
conclusion is based on the values given in 
Table 5 and — especially for elastase — on the 
linear shape of the titration curves. On the other 
hand from the titration curves it is possible to 
Table 4. Estimation of M . W. by Gel Filtration of DSI 
and D Si-Enzyme Complexes 
The chilled (10° C) Sephadex G-75 column used was 
equilibrated and developed with 0.05M TRA-HC1, 
0.15M NaCl, p H 7.0. Of each protein or protein complex 
(containing equimolar amounts of enzyme (s) and in-
hibitor) about 3 mg were applied. Absorption at 253 nm 
as well as enzyme inhibition (after dissociation of the 
complexes with aqueous perchloric acid) were measured 
in the eluates 
Substance v/v0 M . W. 
Dextran blue (V 0) 
Albumin (human) 1.27 68000 
Chymotrypsinogen 1.57 25000 
Cytochrom c 1.86 12000 
BPTI 2.30 6500 
DSI 1.86* 12000 
DSI -f trypsin 1.52 29000C 
DSI -J- chymotrypsin 1.42 39000 
DSI + trypsin and chymo- 1.30* 60000 
trypsin 
a Trypsin and chymotrypsin inhibition paralleled 
exactly in the eluted fractions. 
* Degradation products of lower m. w. were also 
observed. 
c Non additive molecular weights were also found 
with other examples [26]. 
calculate the amount of active enzyme molecules 
present in the enzyme preparations, e. g. in 
subtilisin Novo, A . oryzae protease, and 
elastase (cf. Tab. 5). It is remarkable that the 
activity of subtilisin and elastase was not 
decreased by high amounts (0.3—0.5 mg) of 
BPTI under the same conditions. 
Pronase also contains proteinases which are 
strongly inhibited by DSI : One third of the azo-
casein-splitting activity of pronase was inhibited 
by titration with DSI in a manner characteristic 
for 1:1 complex formation (Fig. 11). That is why 
it is possible to calculate that 1 mg of the pronase 
preparation employed contains 14 n mole of 
DSI-reactive proteinases. 
Porcine plasmin is also inhibited by DSI , but 
much more weaker than the above mentioned 
enzymes (Fig. 6). The complex is already highly 
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Table 5. Enzyme/Inhibitor Ratio in the Complex Calculated from the Titration Curves 
Theoretical amount 
of inhibitor neces-
Enzyme Fig. Substrate used Amount of enzyme sary for complete 
titrated inhibition 
n mole fig n mole 
Trypsin 5 B A P N A 0.28 0.26 
Chymotrypsin 7 CPPN 0.78 0.78 
Subtilisin 8 Azo-casein 25a 0.80 
Elastase 9 Elastin-orcein 750* 0.80 
A . oryzae protease 10 Azo-casein 25* 0.58 
Pronase 11 Azo-casein 50d 0.70 
a Assuming a m. w. of 27500 [43] the subtilisin preparation contains 22 fig of active enzyme. 
b Assuming a m. w. of 28500 [43] the elastase used contains 23 fig of active enzyme. 
c Assuming a m. w. of 19600 [43] the protease used contains 11 jug of active enzyme. 
d Assuming a m. w. of 19000 [44] the pronase preparation contains 13 jug of an enzyme inhibited by DSI. 
Fig. 5. Titration of Bovine Trypsin with Dog Submandibular Inhibitor (DSI), DSI-Chymotrypsin Complex, and 
DSI-Subtilisin Complex. DSI-fraction A 2 (cf. Fig. 2 and Table 1) was used throughout. 
1) Titration with DSI: Constant amounts of trypsin, 0.28 n mole (i. e. about 10 fig by weight), titrated with BPTI, 
were incubated with increasing amounts of DSI in 2.0 ml 0.2M TRA-HC1 (without CaCl2), pH 7.8, for 8 minutes at 
25° C. The enzymatic reaction was started by addition of 1.0 ml substrate solution (1 mg B A P N A in deionized water, 
cf. [11, 12]). Measured at 90% inhibition, no time dependence of the degree of inhibition was observed using preincu-
bation periods from 1 up to 15 minutes. 
2) Titration with DSI-Chymotrypsin Complex: Equimolar amounts of DSI (120 ^ g) and a-chymotrypsin (about 240 fig), 
calculated from the titration curve in Fig. 7 from measurements at 50% inhibition, were preincubated in 5.0 ml 
0.2M TRA-HC1, p H 7.8, for 15 minutes and longer at 0°C. Constant amounts (0.32 n mole) of trypsin were incubated 
with increasing amounts of the DSI-chymotrypsin complex in 2.0 ml TRA-HC1 for 8 minutes at 25°C; the enzymatic 
reaction was started as described above. No time dependence of the degree of inhibition of trypsin (by the DSI-chymo-
trypsin complex) was observed using preincubation periods from 1 up to 15 minutes. On the abscissa only the amount 
of DSI bound in the complex is given. 
3) Titration with DSI-Subtilisin Complex: Equimolar amounts of DSI (103 fig) and subtilisin (about 250 fig), calculated 
from the titration curve in Fig. 8 from measurements at 50% inhibition, were preincubated in 2.24 ml phosphate 
buffer, p H 7.6, for 10 minutes and longer at 0°C. Constant amounts (0.30 n mole) of trypsin were incubated with 
increasing amounts of DSI-subtilisin complex in 2.0 ml 0.2M TRA-HC1, p H 7.8, for 8 minutes at 25°C. The enzy-
matic reaction was started by addition of the BAPNA-substrate solution (cf. Methods and trypsin titration). The 
amount of subtilisin employed caused no BAPNA-hydrolysis. On the abscissa only the amount of DSI bound in the 
complex is given. 
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Fig. 6. Plasmin Inhibition. Constant amounts (250 jug, 1.8 n mole) of plasmin were incubated with increasing amounts 
of DSI (fraction A 2 , cf. Fig. 5) in* 0.2M TRA-HC1, 0.05M L-lysine, p H 7.8, for 8 minutes at 25° C. The enzymatic reac-
tion was started by addition of 1.0 ml BAPNA-substrate solution (cf. Methods and Fig. 5, trypsin titration). Measured 
at 71% inhibition, no time dependence of the degree of inhibition was observed using preincubation periods from 
1 up to 15 minutes. * (2,0 ml). 
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Fig. 7. Titration of Bovine a-Chymotrypsin with DSI and DSI-Trypsin Complex. DSI-fraction Ag (cf. Fig. 2 and 
Table 1) was used throughout. 
1) Titration with DSI: Constant amounts of a-chymotrypsin, 0.78 n mole (i. e. about 20 fig by weight), titrated with 
BPTI, were incubated with increasing amounts of DSI in 2.0 ml 0.2M TRA-HC1, 0.02M CaCl 2 , p H 7.8, for 8 minutes 
at 25°C. The enzymatic reaction was started by addition of 1.0 ml substrate solution (5 mg CPPN in 1.0 ml 0.2M T R A -
HC1, p H 7.8), cf. [12, 15]. Measured at 90% inhibition, the degree of inhibition is constant at preincubation periods 
from 1 up to 15 minutes. 
2) Titration with DSI-Trypsin Complex: Equimolar amounts of DSI (80 /zg) and trypsin (about 200 ^g), calculated from 
the titration curve in Fig. 5 from measurements at 50% inhibition, were preincubated in 6.0 ml 0.2M TRA-HC1, 0.02M 
CaCl 2 , p H 7.8, for 10 minutes and longer at 0 °C . Constant amounts (0.96 n mole) of a-chymotrypsin were incubated 
with increasing amounts of the DSI-trypsin complex for 8 minutes at 25° C; the enzymatic reaction was started by 
addition of the substrate solution (see above). Measured at 90% inhibition, no time dependence of the degree of in-
hibition of a-chymotrypsin (by the DSI-trypsin complex) was observed using preincubation periods from 1 up to 
15 minutes. 
On the abscissa only the amount of DSI bound in the complex is given. 
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Fig. 8. Inhibition of Subtilisin Novo. To constant amounts (25 fig) of subtilisin increasing amounts of DSI (fraction 
A 2 > cf. Fig. 5) were added. The procedure is given in the Methods. Employed substrate: Azo-casein. 
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Fig. 9. Inhibition of Pancreatic Elastase. To constant amounts (0.75 mg) of elastase increasing amounts of DSI (frac-
tion A 2 , cf. Fig. 5) were added. The procedure is given in the Methods. Employed substrate: Elastin-orcein. 
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Fig. 10. Inhibition of Aspergillus Oryzae Protease. To 
constant amounts (25 fig) of the protease increasing 
amounts of DSI (fraction A 2 , cf. Fig. 5) were added. 
The procedure is given in the Methods. Employed 
substrate: Azo-casein. 
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Fig. 11. Inhibiton of Proteolytic Activity of Pronase. To 
constant amounts (50 fig) of Pronase increasing amounts 
of DSI (fraction A 2 , cf. Fig. 5) w^ ere added. The proce-
dure is given in the Methods. Employed substrate: 
Azo-casein. Note, that only part of the proteolytic 
activity (ordinate) is inhibited 
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dissociated in the presence of B A P N A which is a 
substrate with only a small affinity to plasmin. The 
steeper slope of the titration curve at the begin-
ning may be due to a small degree of contamina-
tion with trypsin which was used for the activa-
tion of plasrninogen. 
N o inhibition of collagenase could be demon-
strated. The activity of 0.1 mg of collagenase 
(from Worthington: 159 U/mg; substrate: 
p-phenylazobenzyloxycarbonyl-L-pro-L-leu-gly-
L-pro-D-argOH from Fluka; method accord-
ing to [28]) was neither dlrninished in the 
presence of 0.1 mg DSI nor by 0.5 mg B P H . 
H A E N D L E [8] reported that porcine pancreatic 
kallikrein is also not inhibited by DSI . 
The results show clearly that DSI is a strong 
inhibitor of functional serine proteinases 
belonging to different families of this group [29] : 
In addition to proteinases of the trypsin-chymo-
trypsin family of mammals other serine pro-
teinases from bacteria or mold fungus bearing no 
structural resemblance to the afore mentioned 
ones are also inhibited. It is most interesting that 
the inhibition spectra of ovoinhibitors [19] and 
of inhibitors from potatoes [30] are very similar 
to that of DSI . (See also the following para-
graph.) 
Reac t ive Sites 
Different reactive sites on the DSI-molecule are 
responsible for the inhibition of trypsin and 
chymotrypsin. N o decrease in activity against 
both enzymes is observed after exhaustive 
maleylation; however, if the maleylated DSI-
derivative is reacted with the arginine-modif ying 
butandion-2,3 reagent [31] it retains only its 
inhibitory activity for chymotrypsin. Therefore 
an arginine residue is located in the reactive site 
for trypsin inhibition [32]. 
The formation of ternary complexes is unam-
biguously demonstrated by the titration curves 
given in Figures 5 and 7 and the results of the gel 
filtration experiments (Tab. 4). The binding of 
trypsin therefore does not interfere with the 
binding of chymotrypsin or subtilisin, conse-
quently the DSI-molecule is double-headed with 
not overlapping reactive sites [33]. Very similar 
properties were reported for the ovoinhibitors 
from egg white [19, 34], the inhibitor A A from 
soybeans [35], and the lima bean protease in-
hibitor L B I [21]. 
The subtilisin-DSI complex inhibits trypsin but 
not chymotrypsin. Therefore and from the 
specifity requirements of the proteinases [36] it 
may be deduced that the chymotrypsin-reactive 
site and the subtilisin-reactive site on the DSI-
molecule are identical; this same site may also 
be responsible for the inhibition of elastase [36] 
and perhaps A . oryzae protease. Unfortunately 
DSI is not so easily modified in slightly acidic 
solutions as the Kunitz trypsin inhibitor [37], the 
Bowman-Birk inhibitor A A [35] from soybeans, 
and the inhibitor from lima beans [21] ; investiga-
tions with altered conditions are in progress. 
The results mentioned show that the inhibition 
of chymotrypsin by BPTI is a special case [38, 
39]. The wide inhibition spectrum of DSI as well 
as the similar inhibition spectra of the ovoin-
hibitors are mainly caused by the chymotryptic 
reactive sites of these inhibitor molecules. 
P h y s i o l o g i c a l F u n c t i o n 
The assumption that DSI protects mucosa cells 
in mouth and esophagus against the action of 
proteinases ingested with the food [5, 7—9] is 
supported by our findings: The inhibition of 
subtilisin, elastase and mold proteases by DSI . 
But also a special function of DSI in connection 
with proteinases found in submaxillary glands 
[40] etc. of some animals is possible. 
The inhibition of elastase by DSI may be an 
important fact for the application of this in-
hibitor for medical therapy in future: The 
destruction of connective tissue cells caused by 
elastases during acute pancreatitis [41] or oc^ 
antitrypsin deficiency [42] is possibly prevented 
by DSI . 
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